December 5, 2022
Cell and Gene Therapy Manufacturing and Commercialization
Join World Courier at the Cell and Gene Therapy Manufacturing and Commercialization event in Amsterdam. Meet us in person for this exciting three-day event, to discuss, debate and consider new strategies in manufacturing, commercialization and supply chains.
Over 50 speakers will analyze the techniques and vector technologies to revolutionize the cell and gene edited ex vivo cell therapy programs. Please also join Andrea Zobel's speaking session on December 7 to learn more about cell and gene therapies.
Date: Monday, December 5 to Thursday, December 8
Time: 09:00am – 16:45pm
Venue: Beurs van Berlage Amsterdam
Speaker session
Date: December 7, 2022
Time: 15:00pm – 15:30pm CET
Speaker: Dr Andrea Zobel, Senior Director, Personalized Supply Chain, World Courier
Topic: Are Cell and Gene therapies dangerous goods?
This presentation will cover:
- What are genetically modified organisms, and why are they hazardous?
- How does the dangerous goods classification UN3245 affect the cell and gene therapy supply chain?
- The regulator’s view on the risks of cell and gene therapies.
- A recommendation on how to classify and ship cell and gene therapies.
Meet the team: